7EBR image
Deposition Date 2021-03-10
Release Date 2021-03-31
Last Version Date 2024-10-09
Entry Detail
PDB ID:
7EBR
Keywords:
Title:
EV-D68 in complex with 2H12 Fab (state S2)
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP1
Chain IDs:A
Chain Length:297
Number of Molecules:1
Biological Source:Human enterovirus D68
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP3
Chain IDs:B
Chain Length:247
Number of Molecules:1
Biological Source:Human enterovirus D68
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP2
Chain IDs:C
Chain Length:248
Number of Molecules:1
Biological Source:Human enterovirus D68
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP4
Chain IDs:D
Chain Length:68
Number of Molecules:1
Biological Source:Human enterovirus D68
Polymer Type:polypeptide(L)
Molecule:2H12 Fab heavy chain
Chain IDs:E
Chain Length:216
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:2H12 Fab light chain
Chain IDs:F
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections.
Nat Commun 12 2904 2904 (2021)
PMID: 34006855 DOI: 10.1038/s41467-021-23199-5

Abstact

Enterovirus D68 (EV-D68) is an emerging pathogen associated with respiratory diseases and/or acute flaccid myelitis. Here, two MAbs, 2H12 and 8F12, raised against EV-D68 virus-like particle (VLP), show distinct preference in binding VLP and virion and in neutralizing different EV-D68 strains. A combination of 2H12 and 8F12 exhibits balanced and potent neutralization effects and confers broader protection in mice than single MAbs when given at onset of symptoms. Cryo-EM structures of EV-D68 virion complexed with 2H12 or 8F12 show that both antibodies bind to the canyon region of the virion, creating steric hindrance for sialic acid receptor binding. Additionally, 2H12 binding can impair virion integrity and trigger premature viral uncoating. We also capture an uncoating intermediate induced by 2H12 binding, not previously described for picornaviruses. Our study elucidates the structural basis and neutralizing mechanisms of the 2H12 and 8F12 MAbs and supports further development of the 2H12/8F12 cocktail as a broad-spectrum therapeutic agent against EV-D68 infections in humans.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback